Global Postoperative Management Market, By Indication (Airway Obstruction, Hypoxia, Hemorrhage, Hypotension, Hypertension, Pain, Shivering, Hypothermia, Vomiting, Aspiration, Residual Narcosis), Product Type (Opioids, Fentanyl, Morphine, Meperidine, Non-Steroidal Anti-Inflammatory Drugs, Paracetamol, Ibuprofen, Ketorolac Tromethamine, Celecoxib, Etoricoxib, Rofecoxib, Glucocorticods, Local Anesthetics, Antidepressants, Others), Application (Cancer Pain, Arthritic Pain, Neuropathic Pain, Musculoskeletal Pain, Migraine, Fibromyalgia, Other), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Store, E-Commerce) – Industry Trends and Forecast to 2030.
Postoperative Management Market Analysis and Size
The most frequent reason for admitting particular patients to an ICU or step-down unit is the requirement for intrusive hemodynamic monitoring and observation. The severity of the severe disease and requirement for invasive positive pressure breathing are the fundamental differences between these two environments in the majority of institutions.
Data Bridge Market Research analyses that the global postoperative management market which was USD 35.50 billion in 2022, is expected to reach USD 57.27 billion by 2030, and is expected to undergo a CAGR of 6.16% during the forecast period of 2023 to 2030. “Pain” dominates the indication segment of the global postoperative management market owing to rising awareness about surgical treatments. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Postoperative Management Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Indication (Airway Obstruction, Hypoxia, Hemorrhage, Hypotension, Hypertension, Pain, Shivering, Hypothermia, Vomiting, Aspiration, Residual Narcosis), Product Type (Opioids, Fentanyl, Morphine, Meperidine, Non-Steroidal Anti-Inflammatory Drugs, Paracetamol, Ibuprofen, Ketorolac Tromethamine, Celecoxib, Etoricoxib, Rofecoxib, Glucocorticods, Local Anesthetics, Antidepressants, Others), Application (Cancer Pain, Arthritic Pain, Neuropathic Pain, Musculoskeletal Pain, Migraine, Fibromyalgia, Other), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Store, E-Commerce)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Novartis AG (Switzerland), Eli Lilly and Company (U.S.), Abbott (U.S.), Endo International plc (Ireland), Purdue Pharma L.P. (U.S.), Pfizer, Inc. (U.S.), F. Hoffmann La Roche Ltd. (Switzerland), Merck & Co. Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), GSK Plc. (U.K.), Allergen (Irealnd), Bayer AG (Germany), Bristol-Myers Squibb Company (U.S.), Bausch Health Companies Inc. (Canada), Boehringer Ingelheim International GmbH (Germany), Sorrento Therapeutics, Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Postoperative pain management refers to techniques or strategies for easing patients' post-operative pain. Because of the discomfort, patients' hospital stays are prolonged, and they experience both physical and mental stress. The goal of postoperative pain management is to lessen patients' discomfort after surgery.
Global Postoperative Management Market Dynamics
Drivers
- Rising Awareness about Surgical Treatments
The global postoperative management market is anticipated to be driven by the ever-increasing population and rising awareness about surgical treatments for cancer and other chronic conditions like chronic obstructive pulmonary disease (COPD). The market for postoperative pain treatment is being impacted by the constantly evolving lifestyle preferences and decisions, including plastic surgery and aesthetic reconstruction. Competition among producers of postoperative pain management drugs is anticipated to increase as a result of ongoing attempts by manufacturers to develop new non-opioid medications for the global postoperative management market
- Prevalence of Chronic Disease
The need for postoperative pain treatment techniques is increasing due to factors such as the prevalence of chronic disease, the increase in surgical procedures, the demand for novel non-opioid analgesics in postoperative pain management therapy, and rising awareness of palliative care.
- Growing Consumer Need for Painkillers
According to National Health data, 100 million procedures are performed annually in the U.S. . The excessive consumption of painkillers is mostly caused by the rising number of surgeries performed around the world. Similar to how the prevalence of cancer therapy-related pain is rising, the market is expanding due to an ageing and growing paediatric population having various sorts of surgeries.
Opportunities
- Technological Advancements:
The integration of technology, such as remote monitoring devices, telemedicine, and digital health platforms, provides opportunities for improved postoperative management. These innovations enable real-time monitoring, early detection of complications, and personalized care.
- Shift towards Value based Care
The increasing focus on value-based care encourages healthcare providers to optimize postoperative management, aiming for better patient outcomes, reduced readmissions, and cost savings. This presents opportunities for innovative postoperative management solutions and care co-ordination.
Restraints/Challenges
- Fragmented Healthcare Systems
Fragmentation in healthcare systems, including disjointed care delivery, lack of standardized protocols, and limited communication between healthcare providers, poses challenges to effective postoperative management. Integration and collaboration among different care settings and providers are necessary to overcome this restraint.
- Resource Constraints
Limited healthcare resources, including staffing shortages, financial constraints, and access to specialized care, can hinder optimal postoperative management. Adequate resource allocation and innovative solutions are needed to address these challenges.
This global postoperative management market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global postoperative management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Postoperative Management Market Scope
The global postoperative management market is segmented on the basis of indication, product type, application, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Airway Obstruction
- Hypoxia
- Hemorrhage
- Hypotension
- Hypertension
- Pain
- Shivering
- Hypothermia
- Vomiting
- Aspiration
- Residual Narcosis
Product Type
- Opioids
- Fentanyl
- Morphine
- Meperidine
- Non-Steroidal Anti-Inflammatory Drugs
- Paracetamol
- Ibuprofen
- Ketorolac Tromethamine
- Celecoxib
- Etoricoxib
- Rofecoxib
- Glucocorticods
- Local Anesthetics
- Antidepressants
- Others
Application
- Cancer Pain
- Arthritic Pain
- Neuropathic Pain
- Musculoskeletal Pain
- Migraine
- Fibromyalgia
- Other
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- E-Commerce
Global Postoperative Management Market Regional Analysis/Insights
The global postoperative management market is analysed and market size insights and trends are provided by country, indication, product type, application and distribution channel as referenced above.
The countries covered in the global postoperative management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe dominates the global postoperative management market due to the rise in the incidence of patients with cardiovascular diseases and diabetes. Furthermore, the growing obese population will further boost the growth of the global postoperative management market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the global postoperative management market due to the rise in the incidence of population in demand of medical treatment. Moreover, the growing expenditure to enhance the healthcare infrastructure is further anticipated to propel the growth of the global postoperative management market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed Base and New Technology Penetration
Global postoperative management market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for global postoperative management market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global postoperative management market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Postoperative Management Market Share Analysis
The global postoperative management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global postoperative management market
- Some of the major players operating in the global postoperative management market are:
- Novartis AG (Switzerland)
- Eli Lilly and Company (U.S.)
- Abbott (U.S.)
- Endo International plc (Ireland)
- Purdue Pharma L.P. (U.S.)
- Pfizer, Inc. (U.S.)
- F. Hoffmann La Roche Ltd. (Switzerland)
- Merck & Co. Inc. (U.S.)
- Johnson & Johnson Services Inc. (U.S.)
- GSK Plc. (U.K.)
- Allergen (Irealnd)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (U.S.)
- Bausch Health Companies Inc. (Canada)
- Boehringer Ingelheim International GmbH (Germany)
- Sorrento Therapeutics, Inc (U.S.)
SKU-